Sumitomo Mitsui Financial Group’s Teladoc Health TDOC Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,179	Closed	-$418	–	186
2024 Q1	$418	Buy	+4,179	New	+$75.8K	﹤0.01%	168
2023 Q3	–	Sell	-4,179	Closed	-$2.11K	–	182
2023 Q2	$2.11K	Buy	+4,179	New	+$105K	﹤0.01%	172
2023 Q1	–	Sell	-40,000	Closed	-$47.4K	–	178
2022 Q4	$47.4K	Sell	40,000 -151,500	-79%	-$4.08M	﹤0.01%	152
2022 Q3	$54K	Sell	191,500 -5,303	-3%	-$186K	﹤0.01%	171
2022 Q2	$551K	Sell	196,803 -125,000	-39%	-$5.31M	0.02%	148
2022 Q1	$62K	Sell	321,803 -274,197	-46%	-$19.8M	﹤0.01%	173
2021 Q4	$784K	Buy	596,000 +241,000	+68%	+$28.8M	0.02%	119
2021 Q3	$1.04M	Buy	355,000 +190,000	+115%	+$27.7M	0.02%	113
2021 Q2	$2.01M	Buy	165,000 +105,000	+175%	+$17M	0.04%	94
2021 Q1	$549K	Buy	+60,000	New	+$13.9M	0.01%	126

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sumitomo Mitsui Financial Group's TDOC Position: Q4 2024 in Review

Sumitomo Mitsui Financial Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 4,970 shares — an estimated $42K sold.

Sumitomo Mitsui Financial Group first reported a position in TDOC in Q1 2021 and held it in 15 quarters. The position peaked at $37.7M in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

Sumitomo Mitsui Financial Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
Sumitomo Mitsui Financial Group sold 4,970 Teladoc Health shares in Q4 2024, an estimated $42K.
Sumitomo Mitsui Financial Group first reported a position in Teladoc Health in Q1 2021 and held it in 15 quarters.
Sumitomo Mitsui Financial Group's Teladoc Health position peaked at $37.7M in Q1 2022.
381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q4 2024, filed 13 Feb 2025.